c‐MYC, an oncogenic transcription factor, promotes the EMT process by regulating key markers, including downregulating E‐cadherin and upregulating N‐cadherin, while also interacting with multiple signaling pathways to enhance the invasive and metastatic potential of tumor cells [44, 46, 49]. This evidence concerns the gene CDH2 and neoplasm.